Inventor · disambiguated record
Gary Probst
Also filed as: PROBST GARY · PROBST GARY D
11 granted patents·19 pending applications·73 citations·filing 2005–2021
88Inventor score
Files withIMAGO PHARMACEUTICALS INC8ELAN PHARM INC4MILLENNIUM PHARM INC4JOHN VARGHESE3KONRADI ANDREI W2
Top patents by PatentIndex Score
30 records- 0197US7521470B2Factor Xa inhibitorsMILLENNIUM PHARM INC·Filed 2005·Granted Apr 21, 2009·29 cites·29 claims
- 0296US7696352B2Factor Xa inhibitorsMILLENNIUM PHARM INC·Filed 2007·Granted Apr 13, 2010·22 cites·16 claims
- 0391US8153670B2Factor Xa inhibitorsZHU BING-YAN·Filed 2009·Granted Apr 10, 2012·8 cites·51 claims
- 0482US7385085B2Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitorsELAN PHARM INC·Filed 2005·Granted Jun 10, 2008·6 cites·10 claims
- 0580US7858642B2Substituted hydroxyethylamine aspartyl protease inhibitorsELAN PHARM INC·Filed 2009·Granted Dec 28, 2010·5 cites·24 claims
- 0677US2022081427A1Inhibitors of jun n-terminal kinaseIMAGO PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0771US8377974B2Factor Xa inhibitorsMILLENNIUM PHARM INC·Filed 2011·Granted Feb 19, 2013·1 cites·29 claims
- 0870US9073891B2Inhibitors of Jun N-terminal kinaseSHAM HING L·Filed 2012·Granted Jul 7, 2015·1 cites·6 claims
- 0970US2020277285A1Inhibitors of jun n-terminal kinaseIMAGO PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1068US2020039972A1Inhibitors of jun n-terminal kinaseIMAGO PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1167US2019194176A1Inhibitors of jun n-terminal kinaseIMAGO PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1265US2018319780A1Inhibitors of jun n-terminal kinaseIMAGO PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1363US2018037577A1Inhibitors of jun n-terminal kinaseIMAGO PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1462US9796706B2Inhibitors of Jun N-terminal kinaseIMAGO PHARMACEUTICALS INC·Filed 2016·Granted Oct 24, 2017·0 cites·17 claims
- 1562US2014363454A1Antibody-Drug Conjugates, Compositions and Methods of UseIGENICA BIOTHERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 1658US9884828B2Substituted cinnolines as inhibitors of LRRK2 kinase activityAUBELE DANIELLE L·Filed 2012·Granted Feb 6, 2018·1 cites·23 claims
- 1756US2009042961A1Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitorsELAN PHARM INC·Filed 2008·Application pending·0 cites
- 1856US2015259330A1Inhibitors of jun n-terminal kinaseIMAGO PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 1955US2018147294A1Antibody-drug conjugates, compositions and methods of useJACKSON DAVID Y·Filed 2017·Application pending·0 cites
- 2053US8450363B2Inhibitors of Jun N-terminal kinaseSHAM HING L·Filed 2010·Granted May 28, 2013·0 cites·25 claims
- 2151US8283358B2N-sulfonamido polycyclic pyrazolyl compoundsKONRADI ANDREI W·Filed 2009·Granted Oct 9, 2012·0 cites·24 claims
- 2250US2010234352A1Factor xa inhibitorsMILLENNIUM PHARM INC·Filed 2010·Application pending·0 cites
- 2346US2022062233A1Compounds for the Reduction of the Deleterious Activity of Extended Nucleotide Repeat Containing GenesUNIV LELAND STANFORD JUNIOR·Filed 2019·Application pending·0 cites
- 2445US2008021056A1Fused, Tricyclic Sulfonamide Inhibitors of Gamma SecretaseKONRADI ANDREI W·Filed 2007·Application pending·0 cites
- 2542US2007149525A1Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitorsHOM ROY·Filed 2006·Application pending·0 cites
- 2642US2005239836A1Substituted hydroxyethylamine aspartyl protease inhibitorsJOHN VARGHESE·Filed 2005·Application pending·0 cites
- 2739US2006128715A1Oxime derivative hydroxyethylamine aspartyl-protease inhibitorsSEALY JENNIFER·Filed 2005·Application pending·0 cites
- 2835US2011034691A1Process for the Production of Fused, Tricyclic SulfonamidesELAN PHARM INC·Filed 2010·Application pending·0 cites
- 2935US2005239832A1Methods of treatment of amyloidosis using bi-cyclic aspartyl protease inhibitorsJOHN VARGHESE·Filed 2005·Application pending·0 cites
- 3035US2006014790A1Methods of treatment of amyloidosis using spirocyclohexane aspartyl-protease inhibitorsJOHN VARGHESE·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gary Probst files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →